Cargando…
Combined Treatment with Low Concentrations of Decitabine and SAHA Causes Cell Death in Leukemic Cell Lines but Not in Normal Peripheral Blood Lymphocytes
Epigenetic therapy reverting aberrant acetylation or methylation offers the possibility to target preferentially tumor cells and to preserve normal cells. Combination epigenetic therapy may further improve the effect of individual drugs. We investigated combined action of demethylating agent decitab...
Autores principales: | Brodská, Barbora, Holoubek, Aleš, Otevřelová, Petra, Kuželová, Kateřina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3755446/ https://www.ncbi.nlm.nih.gov/pubmed/24000324 http://dx.doi.org/10.1155/2013/659254 |
Ejemplares similares
-
Decitabine and SAHA-Induced Apoptosis Is Accompanied by Survivin Downregulation and Potentiated by ATRA in p53-Deficient Cells
por: Brodská, Barbora, et al.
Publicado: (2014) -
Group I p21-activated kinases in leukemia cell adhesion to fibronectin
por: Kuželová, Kateřina, et al.
Publicado: (2021) -
NSC348884 cytotoxicity is not mediated by inhibition of nucleophosmin oligomerization
por: Šašinková, Markéta, et al.
Publicado: (2021) -
Localization of AML-related nucleophosmin mutant depends on its subtype and is highly affected by its interaction with wild-type NPM
por: Brodská, Barbora, et al.
Publicado: (2017) -
AML-Related NPM Mutations Drive p53 Delocalization into the Cytoplasm with Possible Impact on p53-Dependent Stress Response
por: Holoubek, Aleš, et al.
Publicado: (2021)